Cargando…
Optimizing Tuberculosis Case Detection through a Novel Diagnostic Device Placement Model: The Case of Uganda
BACKGROUND: Xpert MTB/RIF (Xpert) is being widely adopted in high TB burden countries. Analysis is needed to guide the placement of devices within health systems to optimize the tuberculosis (TB) case detection rate (CDR). METHODS: We used epidemiological and operational data from Uganda (139 sites...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4382196/ https://www.ncbi.nlm.nih.gov/pubmed/25830297 http://dx.doi.org/10.1371/journal.pone.0122574 |
_version_ | 1782364569973293056 |
---|---|
author | Pho, Mai T. Deo, Sarang Palamountain, Kara M. Joloba, Moses Lutaakome Bajunirwe, Francis Katamba, Achilles |
author_facet | Pho, Mai T. Deo, Sarang Palamountain, Kara M. Joloba, Moses Lutaakome Bajunirwe, Francis Katamba, Achilles |
author_sort | Pho, Mai T. |
collection | PubMed |
description | BACKGROUND: Xpert MTB/RIF (Xpert) is being widely adopted in high TB burden countries. Analysis is needed to guide the placement of devices within health systems to optimize the tuberculosis (TB) case detection rate (CDR). METHODS: We used epidemiological and operational data from Uganda (139 sites serving 87,600 individuals tested for TB) to perform a model-based comparison of the following placement strategies for Xpert devices: 1) Health center level (sites ranked by size from national referral hospitals to health care level III centers), 2) Smear volume (sites ranked from highest to lowest volume of smear microscopy testing), 3) Antiretroviral therapy (ART) volume (sites ranked from greatest to least patients on ART), 4) External equality assessment (EQA) performance (sites ranked from worst to best smear microscopy performance) and 5) TB prevalence (sites ranked from highest to lowest). We compared two clinical algorithms, one where Xpert was used only for smear microscopy negative samples versus another replacing smear microscopy. The primary outcome was TB CDR; secondary outcomes were detection of multi-drug resistant TB, number of sites requiring device placement to achieve specified rollout coverage, and cost. RESULTS: Placement strategies that prioritized sites with higher TB prevalence maximized CDR, with an incremental rate of 6.2–12.6% compared to status quo (microscopy alone). Diagnosis of MDR-TB was greatest in the TB Prevalence strategy when Xpert was used in place of smear microscopy. While initial implementation costs were lowest in the Smear Volume strategy, cost per additional TB case detected was lowest in the TB prevalence strategy. CONCLUSION: In Uganda, placement of Xpert devices in sites with high TB prevalence yielded the highest TB CDR at the lowest cost per additional case diagnosed. These results represent novel use of program level data to inform the optimal placement of new technology in resource-constrained settings. |
format | Online Article Text |
id | pubmed-4382196 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-43821962015-04-09 Optimizing Tuberculosis Case Detection through a Novel Diagnostic Device Placement Model: The Case of Uganda Pho, Mai T. Deo, Sarang Palamountain, Kara M. Joloba, Moses Lutaakome Bajunirwe, Francis Katamba, Achilles PLoS One Research Article BACKGROUND: Xpert MTB/RIF (Xpert) is being widely adopted in high TB burden countries. Analysis is needed to guide the placement of devices within health systems to optimize the tuberculosis (TB) case detection rate (CDR). METHODS: We used epidemiological and operational data from Uganda (139 sites serving 87,600 individuals tested for TB) to perform a model-based comparison of the following placement strategies for Xpert devices: 1) Health center level (sites ranked by size from national referral hospitals to health care level III centers), 2) Smear volume (sites ranked from highest to lowest volume of smear microscopy testing), 3) Antiretroviral therapy (ART) volume (sites ranked from greatest to least patients on ART), 4) External equality assessment (EQA) performance (sites ranked from worst to best smear microscopy performance) and 5) TB prevalence (sites ranked from highest to lowest). We compared two clinical algorithms, one where Xpert was used only for smear microscopy negative samples versus another replacing smear microscopy. The primary outcome was TB CDR; secondary outcomes were detection of multi-drug resistant TB, number of sites requiring device placement to achieve specified rollout coverage, and cost. RESULTS: Placement strategies that prioritized sites with higher TB prevalence maximized CDR, with an incremental rate of 6.2–12.6% compared to status quo (microscopy alone). Diagnosis of MDR-TB was greatest in the TB Prevalence strategy when Xpert was used in place of smear microscopy. While initial implementation costs were lowest in the Smear Volume strategy, cost per additional TB case detected was lowest in the TB prevalence strategy. CONCLUSION: In Uganda, placement of Xpert devices in sites with high TB prevalence yielded the highest TB CDR at the lowest cost per additional case diagnosed. These results represent novel use of program level data to inform the optimal placement of new technology in resource-constrained settings. Public Library of Science 2015-04-01 /pmc/articles/PMC4382196/ /pubmed/25830297 http://dx.doi.org/10.1371/journal.pone.0122574 Text en © 2015 Pho et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Pho, Mai T. Deo, Sarang Palamountain, Kara M. Joloba, Moses Lutaakome Bajunirwe, Francis Katamba, Achilles Optimizing Tuberculosis Case Detection through a Novel Diagnostic Device Placement Model: The Case of Uganda |
title | Optimizing Tuberculosis Case Detection through a Novel Diagnostic Device Placement Model: The Case of Uganda |
title_full | Optimizing Tuberculosis Case Detection through a Novel Diagnostic Device Placement Model: The Case of Uganda |
title_fullStr | Optimizing Tuberculosis Case Detection through a Novel Diagnostic Device Placement Model: The Case of Uganda |
title_full_unstemmed | Optimizing Tuberculosis Case Detection through a Novel Diagnostic Device Placement Model: The Case of Uganda |
title_short | Optimizing Tuberculosis Case Detection through a Novel Diagnostic Device Placement Model: The Case of Uganda |
title_sort | optimizing tuberculosis case detection through a novel diagnostic device placement model: the case of uganda |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4382196/ https://www.ncbi.nlm.nih.gov/pubmed/25830297 http://dx.doi.org/10.1371/journal.pone.0122574 |
work_keys_str_mv | AT phomait optimizingtuberculosiscasedetectionthroughanoveldiagnosticdeviceplacementmodelthecaseofuganda AT deosarang optimizingtuberculosiscasedetectionthroughanoveldiagnosticdeviceplacementmodelthecaseofuganda AT palamountainkaram optimizingtuberculosiscasedetectionthroughanoveldiagnosticdeviceplacementmodelthecaseofuganda AT jolobamoseslutaakome optimizingtuberculosiscasedetectionthroughanoveldiagnosticdeviceplacementmodelthecaseofuganda AT bajunirwefrancis optimizingtuberculosiscasedetectionthroughanoveldiagnosticdeviceplacementmodelthecaseofuganda AT katambaachilles optimizingtuberculosiscasedetectionthroughanoveldiagnosticdeviceplacementmodelthecaseofuganda |